Growing Up with CPHD: Lifelong Monitoring and Transitions
At a Glance
Combined Pituitary Hormone Deficiency (CPHD) is a progressive condition requiring lifelong monitoring, as new hormone deficiencies can develop over time. With consistent care, school emergency planning, and a careful transition to adult endocrinology, individuals can enjoy active, healthy lives.
While a diagnosis of Combined Pituitary Hormone Deficiency (CPHD) means a lifelong journey with medical care, it is a journey that can be lived fully and successfully. Understanding how the condition evolves and how to navigate the transition into adulthood will help you and your child feel prepared for every stage of life [1][2].
The Nature of Progressiveness
One of the most important reasons for lifelong care is that CPHD is often “progressive.” This means that even if your child is currently only missing one or two hormones, others may become deficient over time [1][3].
For example, a child might start with only a Growth Hormone (GH) deficiency, but as they grow, the pituitary gland may slowly lose the ability to produce thyroid-stimulating hormone or the hormones that trigger puberty [1][4]. Indefinite monitoring through regular blood tests is the only way to catch these changes early and start treatment before your child begins to feel unwell [1][5].
Navigating School and Childcare
As your child begins daycare or school, ensuring their safety outside the home is critical. If your child has central adrenal insufficiency, you must provide the school with an Emergency Action Plan written by your endocrinologist [6][7]. This plan should clearly instruct teachers or the school nurse on how to recognize an adrenal crisis, how to administer an emergency hydrocortisone injection, and when to call 911 [7][8]. Empowering your child’s caregivers with knowledge is key to their safety.
The Transition to Adult Care
The move from a pediatric endocrinologist to an adult endocrinologist (usually between ages 18 and 21) is a high-risk period [2][5]. During this “transition,” some young adults stop taking their medications or miss appointments because they feel healthy or find the adult medical system confusing [2][1].
To ensure a safe transition:
- Start early: Begin discussing the transition process with your pediatric team when your child is 14 or 15 [2].
- Education: Help your child understand why each medication is vital. For example, knowing that skipping glucocorticoids (hydrocortisone) can lead to a sudden adrenal crisis is life-saving knowledge [6][9].
- Dose Adjustments: As your child stops growing, their growth hormone needs will change. Many adults continue GH at a lower “maintenance dose” because it helps maintain healthy muscle mass, bone strength, and energy levels [2][10].
Reassurance for the Future
Parents often worry about what their child’s future will look like. It is important to know that with optimized, consistent hormone replacement, the outlook is excellent [11][12]:
- Metabolic Health: While CPHD can increase the risk of certain metabolic issues like insulin resistance, regular monitoring and a healthy lifestyle can effectively manage these risks [13][12].
- Fertility and Pregnancy: Many people with CPHD go on to have healthy families. While they may need specialized help from a fertility expert to “jumpstart” the body’s reproductive signals, successful pregnancies and healthy babies are entirely possible [9][14][15].
- Quality of Life: Most individuals with CPHD lead active, productive lives, pursuing careers and hobbies just like their peers [11][9].
Your child’s condition is a part of their life, but with the right care, it does not have to limit their future [11]. Consistent monitoring is not a burden; it is the tool that ensures they stay healthy and strong through every chapter of their lives.
Common questions in this guide
Will my child's CPHD change as they grow older?
How can I keep my child with CPHD safe at school?
When should we start transitioning from pediatric to adult CPHD care?
Will growth hormone treatment still be needed in adulthood?
Can individuals with CPHD have children?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.When should we start the formal 'transition to adult care' process, and which adult endocrinologists do you recommend for patients with complex CPHD?
- 2.How often will you re-test my child's currently 'normal' hormone levels to catch any new deficiencies early?
- 3.Will my child need to continue growth hormone therapy into adulthood for metabolic health, even after they stop growing?
- 4.Can you explain the specific steps we would take to support my child's fertility when they are ready to start a family?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Progression from isolated growth hormone deficiency to combined pituitary hormone deficiency.
Cerbone M, Dattani MT
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2017; (37()):19-25 doi:10.1016/j.ghir.2017.10.005.
PMID: 29107171 - 2
TRENDS IN GROWTH HORMONE STIMULATION TESTING AND GROWTH HORMONE DOSING IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: RESULTS FROM THE ANSWER PROGRAM.
Gordon MB, Levy RA, Gut R, Germak J
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2016; (22(4)):396-405 doi:10.4158/EP14603.OR.
PMID: 26574788 - 3
Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with isolated growth hormone deficiency due to organic causes.
Child CJ, Blum WF, Deal C, et al.
European journal of endocrinology 2016; (174(5)):669-79 doi:10.1530/EJE-15-1203.
PMID: 26888628 - 4
Congenital Hypopituitarism.
Parks JS
Clinics in perinatology 2018; (45(1)):75-91 doi:10.1016/j.clp.2017.11.001.
PMID: 29406008 - 5
Normal or elevated prolactin is a good indicator to show pituitary stalk interruption syndrome in patients with multiple pituitary hormone deficiency.
Eren E, Ongen YD, Ozgur T, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2022; (35(11)):1394-1400 doi:10.1515/jpem-2022-0366.
PMID: 36136319 - 6
A newborn with combined pituitary hormone deficiency developing shock and sludge.
Ueda Y, Aoyagi H, Tajima T
Journal of pediatric endocrinology & metabolism : JPEM 2017; (30(12)):1333-1336.
PMID: 29176025 - 7
Perioperative glucocorticoid management based on current evidence.
Seo KH
Anesthesia and pain medicine 2021; (16(1)):8-15 doi:10.17085/apm.20089.
PMID: 33445232 - 8
Emergency and perioperative management of adrenal insufficiency in children and young people: British Society for Paediatric Endocrinology and Diabetes consensus guidance.
Mushtaq T, Ali SR, Boulos N, et al.
Archives of disease in childhood 2023; (108(11)):871-878 doi:10.1136/archdischild-2022-325156.
PMID: 37045585 - 9
Management of panhypopituitarism during pregnancy: A case report.
van Zundert SKM, Krol CG, Spaan JJ
Case reports in women's health 2021; (32()):e00351 doi:10.1016/j.crwh.2021.e00351.
PMID: 34471611 - 10
Growth Hormone and Insulin-Like Growth Factor-1.
Nicholls AR, Holt RI
Frontiers of hormone research 2016; (47()):101-14 doi:10.1159/000445173.
PMID: 27347885 - 11
Growth without growth hormone in combined pituitary hormone deficiency caused by pituitary stalk interruption syndrome.
Lee SS, Han AL, Ahn MB, et al.
Annals of pediatric endocrinology & metabolism 2017; (22(1)):55-59 doi:10.6065/apem.2017.22.1.55.
PMID: 28443260 - 12
Management of Hypopituitarism.
Alexandraki KI, Grossman A
Journal of clinical medicine 2019; (8(12)) doi:10.3390/jcm8122153.
PMID: 31817511 - 13
Rapidly progressive non-alcoholic fatty liver disease due to hypopituitarism. Report of 5 cases.
Yang Y, Qi ZR, Zhang TT, et al.
Neuro endocrinology letters 2018; (39(2)):99-104.
PMID: 30183204 - 14
Management of hypopituitarism during pregnancy in patients with PROP1-related combined pituitary hormone deficiency: Review of the literature with a case report.
Pigni S, Marsan G, Caputo M, et al.
Pituitary 2025; (29(1)):7.
PMID: 41359080 - 15
Successful Pregnancies After Adequate Hormonal Replacement in Patients With Combined Pituitary Hormone Deficiencies.
Correa FA, Bianchi PHM, Franca MM, et al.
Journal of the Endocrine Society 2017; (1(10)):1322-1330 doi:10.1210/js.2017-00005.
PMID: 29264457
This guide to living with and transitioning care for CPHD is for educational purposes only. Always consult your pediatric or adult endocrinologist before adjusting hormone therapy or emergency care plans.
Get notified when new evidence is published on Non-acquired combined pituitary hormone deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.